Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases.
<h4>Objective</h4>To investigate clinical and laboratory toxicity in patients with unresectable liver metastases, treated with yttrium-90 radioembolization ((90)Y-RE).<h4>Methods</h4>Patients with liver metastases treated with (90)Y-RE, between February 1(st) 2009 and March 3...
Guardado en:
Autores principales: | Maarten L J Smits, Andor F van den Hoven, Charlotte E N M Rosenbaum, Bernard A Zonnenberg, Marnix G E H Lam, Johannes F W Nijsen, Miriam Koopman, Maurice A A J van den Bosch |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/11eae1dedb48492a99511a4c54842131 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The effect of intra-arterial angiotensin II on the hepatic tumor to non-tumor blood flow ratio for radioembolization: a systematic review.
por: Andor F van den Hoven, et al.
Publicado: (2014) -
Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization.
por: Mattijs Elschot, et al.
Publicado: (2013) -
Assessment of radiation sensitivity of unresectable intrahepatic cholangiocarcinoma in a series of patients submitted to radioembolization with yttrium-90 resin microspheres
por: Tommaso Depalo, et al.
Publicado: (2021) -
Outcome and Safety after 103 Radioembolizations with Yttrium-90 Resin Microspheres in 73 Patients with Unresectable Intrahepatic Cholangiocarcinoma—An Evaluation of Predictors
por: Karolin J. Paprottka, et al.
Publicado: (2021) -
Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study
por: Elie Barakat, MD, et al.
Publicado: (2022)